• The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399

  • Sep 23 2024
  • Length: 10 mins
  • Podcast

The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399

  • Summary

  • Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399

    Overview: In this episode, we look at a new study showing increased probability of survival for patients with Alzheimer disease (AD) who take donepezil and memantine together. We review current treatments for AD and address common hesitations in prescribing dual pharmacotherapy, providing vital insights for primary care clinicians.

    Episode resource links:

    • Yaghmaei, E., Lu, H., Ehwerhemuepha, L. et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients.Commun Med 4, 99 (2024). https://doi.org/10.1038/s43856-024-00527-6
    • Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.

    Guest: Jillian Joseph, MPAS, PA-C

    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

    Show More Show Less
activate_samplebutton_t1

What listeners say about The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.